|Public (Nasdaq Helsinki: BIOBV.B)|
|Osmo Suovaniemi (Founder and Chairman of the Board), Semi Korpela (President and CEO)|
|Products||liquid handling equipment|
|Total equity||€23.9 million (2010)|
Biohit was established in 1988 in Finland by Professor Osmo Suovaniemi (M.D., Ph.D.), previously known as the founder of Labsystems. He stepped down from the CEO position in June 2011, but remains actively involved with the company through positions on several advisory boards. Biohit Oyj is a globally operating Finnish biotechnology company. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki since 1999, Small cap/Healthcare. Mr Semi Korpela was appointed CEO in 2011.
Biohit's two businesses are acetaldehyde eliminating products and diagnostics. More than 90% of Biohit's sales occur outside Finland 
The diagnostic product range of Biohit includes the GastroPanel examinations, which are used to aid diagnosis of Helicobacter pylori infection and atrophic gastritis from a blood sample. They are also ideal tools for identification of patients at increased risk of gastric cancer, peptic ulcer disease, gastroesophageal reflux disease (GERD) and deficiencies of vitamin B12, calcium and iron. In addition to this, Biohit offers Quick tests for the detection of •Lactose intolerance •Helicobacter pylori infection •Celiac disease •Screening of colorectal cancer
Acetaldehyde binding products
Biohit also develops and manufactures monoclonal antibodies for research use and use as raw materials for diagnostic industry.
Adopting a systems approach, Biohit also provides laboratory equipment, such as microplate instruments and automates, as well as liquid handling products to support Biohit ELISA tests.
Research, Development, and Intellectual Property
- Harriet Öster (8 October 1998). "Labsystems kasvaa suuren suojassa". Tekniikka & Talous. Retrieved 2009-11-15.
- Osmo Suovaniemi, Helena Hentola (2004). "Aggressive Innovation and Patenting Strategy – the Way to Success and National Well-Being" (PDF). Biohit.
- Biohit Oyj. Annual Report 2012
- Reuters. Overview of Biomet Oyj. https://www.reuters.com/finance/stocks/companyProfile?rpc=66&symbol=BIOBV.HE
- The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients https://clinicaltrials.gov/ct2/show/NCT02315833
- The Efficacy of L-cysteine in Prevention of Cluster Headache https://clinicaltrials.gov/ct2/show/NCT02310828